A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available

NCT00785538 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: IMC-A12
BIOLOGICAL: IMC-A12
BIOLOGICAL: IMC-A12
BIOLOGICAL: IMC-A12
BIOLOGICAL: IMC-A12
BIOLOGICAL: IMC-A12

Sponsor

Eli Lilly and Company